Could Blue Light Cure Diabetes?

Current research is underway that involves engineering pancreatic beta cells, which are activated by blue light that causes the cells to increase the amount of insulin produced. Diabetes currently affects more than 30 million Americans and is the cause of 4.1 million cases of diabetic retinopathy in the United States . The beta cells in […]

Eye Damage May Occur With Use of Bladder Drug

A popular drug used to treat interstitial cystitis of the bladder was shown in a recent study to cause retinal damage in a study presented at the 2019 American Academy of Ophthalmology annual meeting. Researchers examined a database of 4.3 million patients at Kaiser Permanente in Northern California after a report from last year claimed […]

Gene therapy treatment for AMD in clinical trials

Phase 1 clinical trials on a new gene therapy to treat age-related macular degeneration are currently underway in multiple locations around the country. Early results from the trials are offering promising results and researchers hope gene therapy for wet macular degeneration will be available within the next 3 to 5 years. This new therapy would […]

New Drug for Dry Macular Degeneration?

A new drug to treat the “dry” form of macular degeneration is currently undergoing clinical trials. Allegro Ophthalmics has reported encouraging results from the phase 2 study of Risuteganib. The small phase 2 study involved 40 patients and was conducted over a 28 week period with participants receiving 2 injections. Half of the patients received […]

New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, BeovuĀ®, for the treatment of wet age-related macular degeneration (AMD). BeovuĀ® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Digital therapy for children with ‘lazy eye’

A new digital therapy platform has been released to help patients with amblyopia, otherwise known as “lazy eye”. The subscription-based technology is available from the startup, AmblyoPlay. Progress can be monitored through a progression tracker and shared with eye care providers. Amblyopia is the most common visual impairment in children, with up to 3% of […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

FDA approves trifocal cataract surgery lens

The Food and Drug Administration (FDA) has recently approved the first trifocal intraocular lens from Alcon, for use in patients undergoing cataract surgery in the United States. Clinical studies demonstrated that the lens offers patients outstanding near, intermediate and distance vision while also reducing the need for glasses post-op. With more than 4 million cataract […]

Air pollution a factor in macular degeneration

Study results recently published in the Journal of Investigative Medicine point to a link between air pollutants and an increased risk of developing age-related macular degeneration. This is the first study to show a notable association between macular degeneration and high levels of atmospheric pollution. The study was conducted in Taiwan and involved tracking levels […]

Medication for Dry Macular Degeneration Coming Soon?

While Wet Macular Degeneration has enjoyed the fruits of great research and effective medications, the more common Dry Macular Degeneration has no similar medications for treatment. That might be changing soon. The company, Allegro Ophthalmics, LLC, has developed the molecule, Risuteganib, which the company states is effective against the oxidative stress in the retina that […]